| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |